scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1017756295 |
P356 | DOI | 10.1023/B:JOCI.0000019779.56180.A2 |
P698 | PubMed publication ID | 15024181 |
P2093 | author name string | Wei-Chen Lee | |
Miin-Fu Chen | |||
Hui-Chuan Wang | |||
Min-Ru Wang | |||
Shin-Ru Lia | |||
Yang-Jen Chiang | |||
P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
Dendritic cells and the control of immunity | Q27860918 | ||
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability | Q29617252 | ||
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
The Fas counterattack: cancer as a site of immune privilege | Q33542332 | ||
Impediments to successful immunotherapy | Q33586651 | ||
Effects of TGF-beta on the immune system: implications for cancer immunotherapy. | Q33713481 | ||
Interleukin-10: a cytokine used by tumors to escape immunosurveillance | Q33717191 | ||
Signaling defects in T lymphocytes of patients with malignancy | Q33740933 | ||
The role for transforming growth factor-beta (TGF-beta) in human cancer | Q33828205 | ||
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes | Q34396514 | ||
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 | ||
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
The role of surface HLA-A,B,C molecules in tumour immunity | Q35475241 | ||
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand | Q36367323 | ||
Altered immune responses in interleukin 10 transgenic mice | Q36377330 | ||
Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma | Q36763316 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Increased interleukin-10 serum levels in patients with solid tumours. | Q40936263 | ||
Dendritic cells presenting tumor antigen. | Q41320950 | ||
Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back | Q41465258 | ||
Reversal of tumor-induced immunosuppression: a new approach to cancer therapy | Q41496259 | ||
T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. | Q41697252 | ||
Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. | Q52999151 | ||
In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma. | Q53462875 | ||
Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. | Q53803561 | ||
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis | Q57080563 | ||
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance | Q72230111 | ||
The natural history of hepatocellular carcinoma. A study of 100 untreated cases | Q72742215 | ||
Induction of tolerance by IL-10-treated dendritic cells | Q73873437 | ||
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients | Q74079403 | ||
P433 | issue | 2 | |
P304 | page(s) | 145-154 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Journal of Clinical Immunology | Q6294961 |
P1476 | title | Functional impairment of dendritic cells caused by murine hepatocellular carcinoma | |
P478 | volume | 24 |
Q36040825 | Antisense therapy for restenosis following percutaneous coronary intervention. |
Q37829504 | Immunotherapeutic modulation of the suppressive liver and tumor microenvironments |
Q51536303 | Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy. |
Q51544498 | Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy. |
Q79445998 | Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton |
Search more.